🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
TNG
$TNGX
🔒 US EquitiesTango Therapeutics Inc
AVG HISTORICAL GAP
-2.64%
MAX GAP RECORD
-41.12%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $TNGX
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$TNGX
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 12, 2026 Earnings Release 2026-08-12 (BEFORE OPEN) |
-0.99%
|
| May 13, 2026 Earnings Release 2026-05-13 (AFTER CLOSE) |
-7.76%
|
| Mar 05, 2026 Earnings Release 2026-03-05 (BEFORE OPEN) |
-1.21%
|
| Nov 04, 2025 Earnings Release 2025-11-04 (BEFORE OPEN) |
-1.50%
|
| Aug 05, 2025 Earnings Release 2025-08-05 (BEFORE OPEN) |
+1.97%
|
| May 12, 2025 Earnings Release 2025-05-12 (BEFORE OPEN) |
+2.63%
|
| Feb 27, 2025 Earnings Release 2025-02-27 (UNDETERMINED) |
+0.00%
|
| Nov 06, 2024 Earnings Release 2024-11-06 (BEFORE OPEN) |
-41.12%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
6.0%
Bullish Gaps (6)
Bearish Gaps (5)
Neutral / Flat (2)
📖 Intelligence Summary
Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need. The company was founded by Alan Ashworth, William G….
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗